Epi Pen s High Price Due To Broken Health System, CEO Heather Bresch Says, TODAY

Heather Bresch, CEO of the Mylan pharmaceutical company, says she blames a broken healthcare system for the skyrocketing price of EpiPens. In the wake of growing backlash, the company says the company will offer coupons and financial assistance to purchase the injectors. But some lawmakers dismiss it as a PR move. NBCs Kristen Welker reports for TODAY from Washington, D. C. Subscribe to TODAY: Watch the latest from TODAY: About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage our original web series. Connect with TODAY Online Visit TODAY s Website: Find TODAY on Facebook: Follow TODAY on